New Key Statistics Module, Z-Score and F-Score
NAS:CTKB Key Ratios
| Market Cap $ M | 544.34 |
| Enterprise Value $ M | 309.59 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | 339.03 |
| Price/Book | 1.66 |
| Price/Sales | 2.64 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 204.00 |
| EPS (TTM) $ | -0.57 |
| Beneish M-Score | -3.5 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -8.72 |
| EV-to-EBITDA | -13.12 |
| PEG | -- |
| Shares Outstanding M | 129.14 |
| Net Margin (%) | -36.25 |
| Operating Margin % | -21.49 |
| Pre-tax Margin (%) | -17.61 |
| Quick Ratio | 4.07 |
| Current Ratio | 4.69 |
| ROA % (ttm) | -15.54 |
| ROE % (ttm) | -20.50 |
| ROIC % (ttm) | -22.71 |
| Dividend Yield % | -- |
| Altman Z-Score | 3.30 |
CTKB Number of Guru Trades
CTKB Volume of Guru Trades
Gurus Latest Trades with NAS:CTKB
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:CTKB is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Cytek Biosciences Inc Insider Transactions
No Available Data
News about NAS:CTKB
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers